MicroCal PEAQ-DSC

MicroCal PEAQ-DSC

基本信息

项目摘要

PCHPI Project Summary Essentially every step in the HIV life cycle interfaces intimately with the host cell machinery. The Pittsburgh Center of HIV Protein Interactions focuses on the steps and interactions that occur with the host after engagement of cell surface receptors and membrane fusion through integration of the viral genome into that of the host, the so called “early events”. Several essential molecular interactions and enzymatic activities occur within this time window, necessary for productive progression of the viral life cycle. Thus, it represents a pivotal period in the infection process, during which the susceptibility of the virus to disruptive interventions is likely to be high and little explored. Broadly speaking, the processes that we focus on include uncoating (the process by which the capsid disassembles), reverse transcription, evasion from innate immune factors, nuclear entry and integration. Given the importance of the capsid structure and its interactions for many of these processes, we also explore maturation and in particular formation of the capsid core. We are building on our successes and applying the extensive and complementary experimental expertise of our team to carry out 1) biochemical and high-resolution structure studies of individual proteins and complexes, 2) biochemical, biophysical, and proteomics analyses to identify novel interactions and complexes, 3) virology and imaging studies to understand protein function in the context of the cell and virus infection, and 4) computational analyses to elucidate the physical basis of capsid formation and capsid interactions with binding partners. Broadly, the program comprises projects on capsid interactions, the engagement of Vpr with the DNA repair machinery, and retroviral intasome structure. The requested administrative supplement will provide funds for the purchase of a differential scanning calorimeter, instrumentation essential for continued rigor in our protein production and characterization pipeline toward high-resolution structures of HIV-host protein complexes. Relevance Results provided by the proposed research are expected to have major implications in the global fight against AIDS, still considered an incurable disease with a pressing need for new therapeutic strategies and novel drug targets. Identifying and characterizing atomic structures of key HIV-1 host protein interactions in the immediate post-entry stage of the virus lifecycle will open new avenues in this endeavor.
PCHPI项目摘要 本质上,HIV生命周期的每个步骤与宿主细胞机械紧密地接口。匹兹堡 HIV蛋白相互作用的中心侧重于与宿主发生的步骤和相互作用之后 通过将病毒基因组整合到该基因组中的细胞表面受体和膜融合的参与 主持人,所谓的“早期事件”。发生了几种必需的分子相互作用和酶活性 在这个时间窗口中,对于病毒生命周期的生产效率所必需。那是一个代表 感染过程中的关键时期,在此期间,病毒对干预措施的敏感性为 可能很高,很少探索。从广义上讲,我们关注的过程包括无涂层( 衣壳分解的过程),逆转录,先天免疫因子的进化,核 进入和集成。鉴于衣壳结构的重要性及其相互作用对其中的许多 过程,我们还探索了成熟,特别是CAPSID核心的形成。我们正在建立我们的 成功并应用团队的广泛实验专家进行1) 单个蛋白质和复合物的生化和高分辨率结构研究,2)生化, 生物物理和蛋白质组学分析以识别新型相互作用和复合物,3)病毒学和成像 在细胞和病毒感染的背景下了解蛋白质功能的研究,以及4)计算 分析以阐明衣壳形成的物理基础和与结合伴侣的capsid相互作用。 从广义上讲,该计划包括有关CAPSID互动的项目,VPR与DNA维修的参与 机械和逆转录病毒的内压结构。请求的行政补品将为 购买差异扫描量热仪,仪器对于我们蛋白质的持续严格必不可少的仪器 生产和表征管道朝着HIV宿主蛋白复合物的高分辨率结构。 关联 拟议研究提供的结果预计将对全球斗争产生重大影响 艾滋病仍然被认为是一种无法治愈的疾病,迫切需要新的治疗策略和新型药物 目标。识别和表征关键HIV-1宿主蛋白相互作用的原子结构 病毒生命周期的立即进入后阶段将在这项工作中开放新的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

ANGELA M. GRONENBO...的其他基金

Molecular, Cellular and Behavioral Impact of the R203W PACS1 Syndrome Mutation
R203W PACS1 综合征突变的分子、细胞和行为影响
  • 批准号:
    10440654
    10440654
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10653244
    10653244
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Pittsburgh Center for HIV Protein Interactions (PCHPI)
匹兹堡 HIV 蛋白质相互作用中心 (PCHPI)
  • 批准号:
    10506945
    10506945
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Pittsburgh Center for HIV Protein Interactions (PCHPI)
匹兹堡 HIV 蛋白质相互作用中心 (PCHPI)
  • 批准号:
    10653242
    10653242
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
NMR Core
核磁共振核心
  • 批准号:
    10506950
    10506950
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10506946
    10506946
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
NMR Core
核磁共振核心
  • 批准号:
    10653256
    10653256
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Molecular, Cellular and Behavioral Impact of the R203W PACS1 Syndrome Mutation
R203W PACS1 综合征突变的分子、细胞和行为影响
  • 批准号:
    10612914
    10612914
  • 财政年份:
    2022
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Structural characterization of interacting and aggregating cataract-associated crystallins
白内障相关晶状体蛋白相互作用和聚集的结构表征
  • 批准号:
    10463640
    10463640
  • 财政年份:
    2019
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Structural characterization of interacting and aggregating cataract-associated crystallins
白内障相关晶状体蛋白相互作用和聚集的结构表征
  • 批准号:
    10395057
    10395057
  • 财政年份:
    2019
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:

相似海外基金

Molecularly Targeted Probes for Photodynamic Therapy and Imaging of Breast Cancer
用于乳腺癌光动力治疗和成像的分子靶向探针
  • 批准号:
    10738388
    10738388
  • 财政年份:
    2023
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
The Center for Synovial Sarcoma Biology and Therapeutics
滑膜肉瘤生物学和治疗中心
  • 批准号:
    10797558
    10797558
  • 财政年份:
    2023
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Administrative Supplement - First-in-human clinical translation of a near-infrared, nerve-specific fluorophore to facilitate tissue-specific fluorescence-guided surgery
行政补充-近红外神经特异性荧光团的首次人体临床转化,以促进组织特异性荧光引导手术
  • 批准号:
    10862946
    10862946
  • 财政年份:
    2023
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Investigating the effect of alcohol exposure on human cortical development using a 3D in vitro model
使用 3D 体外模型研究酒精暴露对人类皮质发育的影响
  • 批准号:
    10811223
    10811223
  • 财政年份:
    2023
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别:
Chronic Intermittent Hypoxia and Hyperalgesic Priming - Administrative Supplement
慢性间歇性缺氧和痛觉过敏启动 - 行政补充
  • 批准号:
    10844191
    10844191
  • 财政年份:
    2023
  • 资助金额:
    $ 13.25万
    $ 13.25万
  • 项目类别: